Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Anne Quillet"'
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/a35cc62ebfd74f2194b22c29b2f7c193
Autor:
Sarah Cadot, Chloe Audebert, Charlotte Dion, Soleakhena Ken, Loic Dupré, Laetitia Largeaud, Camille Laurent, Loic Ysebaert, Fabien Crauste, Anne Quillet-Mary
Publikováno v:
PLoS Medicine, Vol 21, Iss 7, p e1004430 (2024)
BackgroundOne of the first clinical observations of ibrutinib activity in the treatment of chronic lymphocytic leukemia (CLL) is a rapid decline in lymph nodes size. This phenomenon is accompanied by an hyperlymphocytosis, either transient or prolong
Externí odkaz:
https://doaj.org/article/f17d8dafc0d34daa9927d03be3be13de
Autor:
Clare H. Robinson, Jonathan P. Ritson, Danielle M. Alderson, Ashish A. Malik, Robert I. Griffiths, Andreas Heinemeyer, Angela V. Gallego-Sala, Anne Quillet, Bjorn J.M. Robroek, Chris Evans, Dave M. Chandler, David R. Elliott, Emma L. Shutttleworth, Erik A. Lilleskov, Ezra Kitson, Filipa Cox, Fred Worrall, Gareth D. Clay, Ian Crosher, Jennifer Pratscher, Jon Bird, Jonathan Walker, Lisa R. Belyea, Marc G. Dumont, Nichole G.A. Bell, Rebekka R.E. Artz, Richard D. Bardgett, Roxane Andersen, Simon M. Hutchinson, Susan E. Page, Tim J. Thom, William Burn, Martin G. Evans
Publikováno v:
Mires and Peat, Vol 29, Iss 02, Pp 1-36 (2023)
Globally, major efforts are being made to restore peatlands to maximise their resilience to anthropogenic climate change, which puts continuous pressure on peatland ecosystems and modifies the geography of the environmental envelope that underpins pe
Externí odkaz:
https://doaj.org/article/271ed4995dde4be88e11c018766b1671
Autor:
Javier Rey-Barroso, Alice Munaretto, Nelly Rouquié, Aurélie Mougel, Malika Chassan, Sébastien Gadat, Océane Dewingle, Renaud Poincloux, Sarah Cadot, Loïc Ysebaert, Anne Quillet-Mary, Loïc Dupré
Publikováno v:
Haematologica, Vol 109, Iss 3 (2023)
The Bruton tyrosine kinase (BTK) inhibitor ibrutinib is widely used for treatment of patients with relapsed/refractory or treatment-naïve chronic lymphocytic leukemia (CLL). A prominent effect of ibrutinib is to disrupt the retention of CLL cells fr
Externí odkaz:
https://doaj.org/article/29c100f1121c45a9b80d70916791602f
Autor:
Sarah Cadot, Carine Valle, Marie Tosolini, Frederic Pont, Laetitia Largeaud, Camille Laurent, Jean Jacques Fournie, Loic Ysebaert, Anne Quillet-Mary
Publikováno v:
Biomarker Research, Vol 8, Iss 1, Pp 1-13 (2020)
Abstract Background Ibrutinib, an irreversible Bruton Tyrosine Kinase (BTK) inhibitor, has revolutionized Chronic Lymphocytic Leukemia (CLL) treatment, but resistances to ibrutinib have emerged, whether related or not to BTK mutations. Patterns of CL
Externí odkaz:
https://doaj.org/article/e2fc737158c04f7ba4a2fdea4933707f
Autor:
Martin Gauthier, Françoise Durrieu, Elodie Martin, Michael Peres, François Vergez, Thomas Filleron, Lucie Obéric, Fontanet Bijou, Anne Quillet Mary, Loic Ysebaert
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Eradication of minimal residual disease (MRD), at the end of Fludarabine-Cyclophosphamide-Rituximab (FCR) treatment, is a validated surrogate marker for progression-free and overall survival in chronic lymphocytic leukaemia. But s
Externí odkaz:
https://doaj.org/article/ca51332e1168470592babd22abe18c80
Autor:
Loic Ysebaert, Anne Quillet-Mary, Marie Tosolini, Frederic Pont, Camille Laurent, Jean-Jacques Fournié
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
High-definition transcriptomic studies through single-cell RNA sequencing (scRNA-Seq) have revealed the heterogeneity and functionality of the various microenvironments across numerous solid tumors. Those pioneer studies have highlighted different ce
Externí odkaz:
https://doaj.org/article/5381e4055ad240e4af7ab5295a907b0c
Autor:
Juan-Pablo Cerapio, Marion Perrier, Camille-Charlotte Balança, Pauline Gravelle, Fréderic Pont, Christel Devaud, Don-Marc Franchini, Virginie Féliu, Marie Tosolini, Carine Valle, Fréderic Lopez, Anne Quillet-Mary, Loic Ysebaert, Alejandra Martinez, Jean Pierre Delord, Maha Ayyoub, Camille Laurent, Jean-Jacques Fournie
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
γδ T lymphocytes diverge from conventional T CD8 lymphocytes for ontogeny, homing, and antigen specificity, but whether their differentiation in tumors also deviates was unknown. Using innovative analyses of our original and ~150 published single-c
Externí odkaz:
https://doaj.org/article/78cd3c370634474b9f9993cdc250af9f
Autor:
Srdana Grgurevic, Patricia Montilla-Perez, Alice Bradbury, Julia Gilhodes, Sophie Queille, Sandrine Pelofy, Aurélien Bancaud, Thomas Filleron, Loïc Ysebaert, Christian Récher, Guy Laurent, Jean-Jacques Fournié, Christophe Cazaux, Anne Quillet-Mary, Jean-Sébastien Hoffmann
Publikováno v:
Haematologica, Vol 103, Iss 6 (2018)
Alteration in the DNA replication, repair or recombination processes is a highly relevant mechanism of genomic instability. Despite genomic aberrations manifested in hematologic malignancies, such a defect as a source of biomarkers has been underexpl
Externí odkaz:
https://doaj.org/article/fb475d78aec04e248a296855f47de9e2
Autor:
Pauline Gravelle, Marie Tosolini, Juan-Pablo Cerapio, Frédéric Pont, Maha Ayyoub, Camille Laurent, Virginie Féliu, Carine Valle, Anne Quillet-Mary, Alejandra Martinez, Loic Ysebaert, Camille-Charlotte Balança, Christel Devaud, Jean-Jacques Fournié, Don-Marc Franchini, Frédéric Lopez, Marion Perrier, Jean Pierre Delord
Publikováno v:
OncoImmunology
OncoImmunology, Taylor & Francis, In press, ⟨10.1080/2162402X.2021.1939518⟩
OncoImmunology, 2021, 10 (1), ⟨10.1080/2162402X.2021.1939518⟩
OncoImmunology, Taylor & Francis, 2021, 10 (1), ⟨10.1080/2162402X.2021.1939518⟩
OncoImmunology, Vol 10, Iss 1 (2021)
OncoImmunology, In press, ⟨10.1080/2162402X.2021.1939518⟩
Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Taylor & Francis, In press, ⟨10.1080/2162402X.2021.1939518⟩
OncoImmunology, 2021, 10 (1), ⟨10.1080/2162402X.2021.1939518⟩
OncoImmunology, Taylor & Francis, 2021, 10 (1), ⟨10.1080/2162402X.2021.1939518⟩
OncoImmunology, Vol 10, Iss 1 (2021)
OncoImmunology, In press, ⟨10.1080/2162402X.2021.1939518⟩
Oncoimmunology
article-version (VoR) Version of Record
International audience; γδ T lymphocytes diverge from conventional T CD8 lymphocytes for ontogeny, homing, and antigen specificity, but whether their differentiation in tumors also deviates was unknown. Using innovative analyses of our original and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efa0d5a3a131f13bd759f5f6c38604df
https://hal.archives-ouvertes.fr/hal-03365502/document
https://hal.archives-ouvertes.fr/hal-03365502/document
